Nanogels as pharmaceutical carriers: finite networks of infinite capabilities
- PMID: 19562807
- PMCID: PMC2872506
- DOI: 10.1002/anie.200900441
Nanogels as pharmaceutical carriers: finite networks of infinite capabilities
Abstract
Nanogels are swollen nanosized networks composed of hydrophilic or amphiphilic polymer chains. They are developed as carriers for the transport of drugs, and can be designed to spontaneously incorporate biologically active molecules through formation of salt bonds, hydrogen bonds, or hydrophobic interactions. Polyelectrolyte nanogels can readily incorporate oppositely charged low-molecular-mass drugs and biomacromolecules such as oligo- and polynucleotides (siRNA, DNA) as well as proteins. The guest molecules interact electrostatically with the ionic polymer chains of the gel and become bound within the finite nanogel. Multiple chemical functionalities can be employed in the nanogels to introduce imaging labels and to allow targeted drug delivery. The latter can be achieved, for example, with degradable or cleavable cross-links. Recent studies suggest that nanogels have a very promising future in biomedical applications.
Figures
References
-
- Vinogradov SV, Batrakova EV, Kabanov AV. Coll. Surf. B: Biointerfaces. 1999;16:291–304.
-
- Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, Nguyen HK, Ochietti B, Suzdaltseva YG, Bartakova EV, Bronich TK, St-Pierre Y, Alakhov VY, Kabanov AV. J. Drug Target. 2000;8:91–105. - PubMed
-
- Sunamoto J, Akiyoshi K. Macromolecules. 1993;26:3062–3068.
-
- Morimoto N, Hasegawa U, Sugawara A, Yamane S, Akiyoshi K. In: Nanotechnology in Carbohydrate Chemistry. Yuassa H, editor. Transworld Research Network; Trivandrum, India: 2006. pp. 67–85.
-
- Vinogradov SV, Bronich TK, Kabanov AV. Adv Drug Deliv Rev. 2002;54:135–147. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RR021937/RR/NCRR NIH HHS/United States
- CA102791/CA/NCI NIH HHS/United States
- NS050660/NS/NINDS NIH HHS/United States
- R01 NS036229/NS/NINDS NIH HHS/United States
- NS36229/NS/NINDS NIH HHS/United States
- R01 CA116591/CA/NCI NIH HHS/United States
- CA89225/CA/NCI NIH HHS/United States
- R01 CA089225/CA/NCI NIH HHS/United States
- P20 RR021937/RR/NCRR NIH HHS/United States
- R01 NS050660/NS/NINDS NIH HHS/United States
- R01 CA102791/CA/NCI NIH HHS/United States
- NS051335/NS/NINDS NIH HHS/United States
- CA116591/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
